Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sarcoma 32Ovarian Neoplasms 12Leiomyosarcoma 12Liposarcoma 10Neoplasms 7Sarcoma, Ewing 4Neoplasm Metastasis 4Liposarcoma, Myxoid 4Sarcoma, Synovial 3Rhabdomyosarcoma 3Histiocytoma, Malignant Fibrous 3Breast Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Osteosarcoma 2Neurofibrosarcoma 2Neoplasms by Site 2Mesothelioma, Malignant 2Malignant mesenchymal tumor 2Ichthyosis, X-Linked 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Bone Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

binimetinib 2Sodium Chloride 2Aminolevulinic Acid 2palbociclib 1methyl 5-aminolevulinate 1ipatasertib 1exemestane 1encorafenib 1baricitinib 1atezolizumab 1Vemurafenib 1VP-102 1Trabectedin 1Spironolactone 1Radiotherapy 1Radiation 1Photochemotherapy 1Paclitaxel 1Low-Level Light Therapy 1Leuprolide 1Injections, Intradermal 1Gonadotropin-Releasing Hormone 1Fluorouracil 1Floderm topical cream 1Everolimus 1Equipment and Supplies 1Docetaxel 1Dacarbazine 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Diseases × Trabectedin × Clear all
NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
53 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡